Stock screener

KROS

Conviction 34HealthcareScan · Mon, Aug 10, 2026
KROS$10.72-3.86%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
3
Vol MA14 232.23K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Keros Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.kerostx.com
Price10.72
Change-3.86%
Gap-1.57%
Rel volume2.31×
Avg volume215.51K
Avg $ vol2.25M
SMA 2010.39
SMA 5010.62
SMA 20014.13
Price vs 50+0.94%
Price vs 200-24.11%
MA stackmixed
50/200 cross
Supertrenddown · 11.42
RSI (14)53
MACD hist0.09
MACD crossbull · 2d
Stoch %K / %D66 / 78
ADX (14)18
+DI / −DI21 / 12
RSI divergence
MACD divergence
ATR %+4.97%
ADR %4.72%
52w high21.84
52w low9.91
From 52w high-50.92%
Above 52w low+8.17%
New 52w highNo
SqueezeOn · 1d
Bollinger width13.02%
%B0.74
Donchian pos65.61%
Donchian high11.26
Donchian low9.69
AVWAP (52w high)14.07
vs AVWAP high-23.80%
AVWAP (52w low)10.72
vs AVWAP low+0.01%
OBV trendDown
Chaikin MF (20)0.04
Today vs 20d2.31×
Avg vol (14d)232.23K
Avg vol (20d)215.51K
Avg $ vol (20d)2.25M
Market cap212.55M
RS 3m (vs SPY)-9.91%
RS 6m (vs SPY)-49.44%
RS line new highNo
Trend template1/8
Technical rank22.9
1 week+6.03%
1 month-9.15%
3 months-11.18%
6 months-38.99%
1 year-19.76%
YTD-42.18%
P/E2.44
P/B0.81
P/S0.87
P/FCF2.01
EPS2.30
Div yield
ROE33.17%
ROA30.26%
Debt/Eq
Current21.96
EV/EBITDA
Gross margin
Net margin35.65%
Rev growth
EPS growth146.44%
Price target
Target upside
Analyst rating
Institutional
Ent. value-45.06M
Revenue0
Net income-28.71M
Gross profit
Free cash flow105.95M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out19.79M
Employees87
ListedWed, Apr 8, 2020
Free float18.42M
Float %93.1%
Short interest1.06M
Days to cover4.1d
Short volume39.2%
Squeeze score47 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeD
Conviction34 / 100
Pattern quality
Tech rank22.9 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance11.83
Support9.76
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KROS

All disclosures →
No recent disclosed trades by Congress in KROS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KROS · 5 buys · 3 sells

InsiderSideShares
BIENAIME JEAN JACQUES
Director · Common Stock · 2026-07-15
Buy1K
BIENAIME JEAN JACQUES
Director · Common Stock · 2026-06-15
Buy1K
Knowles Julius
Director · Common Stock · 2026-06-04
Sell2.63K
Farzan Nima
Director · Common Stock · 2026-06-04
Sell2.63K
Knowles Julius
Director · Common Stock · 2026-06-04
Other
Seth Alpna
Director · Common Stock · 2026-06-04
Sell2.63K
Knowles Julius
Director · Common Stock · 2026-06-03
Other
Farzan Nima
Director · Stock Option (right to buy) · 2026-06-03
Grant7.43K
Farzan Nima
Director · Common Stock · 2026-06-03
Grant7.14K
Seth Alpna
Director · Common Stock · 2026-06-03
Grant7.14K

SEC filings

EDGAR filings in KROS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.